SCHEMBL6201230

SCHEMBL6201230

Cn1ncc(Br)c1-c1cc(F)cc(NC(=O)Nc2ccc(Br)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.61
HTR2C P28335 17/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6198042 0.94 HTR2A (0.64) HTR2AHTR2C
SCHEMBL6198366 0.91 HTR2A (0.73) HTR2AHTR2C
SCHEMBL6194251 0.90 HTR2A (0.61) HTR2AHTR2C
SCHEMBL6199690 0.90 HTR2A (0.59) HTR2AHTR2C
SCHEMBL6197155 0.89 HTR2A (0.66) HTR2AHTR2C
SCHEMBL6198353 0.88 HTR2A (0.56) HTR2AHTR2C
SCHEMBL6197871 0.86 HTR2A (0.62) HTR2AHTR2C
SCHEMBL6197227 0.85 HTR2A (0.61) HTR2AHTR2C
SCHEMBL6199168 0.84 HTR2A (0.58) HTR2AHTR2C
SCHEMBL6200652 0.84 HTR2A (0.66) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509505-A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2005-03-02 EP claimed
WO-2003062206-A2 SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2003-07-31 WO claimed